Addiction

Article	Citations
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)	191
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data	174
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis	121
Gateway or common liability? A systematic review and meta‐analysis of studies of adolescent e‐cigarette use and future smoking initiation	116
Expert appraisal of criteria for assessing gaming disorder: an international Delphi study	115
Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries	102
African Americans now outpace whites in opioid‐involved overdose deaths: a comparison of temporal trends from 1999 to 2018	102
Drug checking services for people who use drugs: a systematic review	92
Shifts in alcohol consumption during the COVID‐19 pandemic: early indications from Australia	88
A meta‐analysis of problem gambling risk factors in the general adult population	77
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis	74
Heroin use cannot be measured adequately with a general population survey	72
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration	63
Causal mechanisms proposed for the alcohol harm paradox—a systematic review	57
Alcohol use in pregnancy and its impact on the mother and child	53
Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States	53
Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England	53
Changes in alcohol consumption associated with social distancing and self‐isolation policies triggered by COVID‐19 in South Australia: a wastewater analysis study	51
The associations between prenatal cannabis use disorder and neonatal outcomes	48
COVID‐19, smoking, vaping and quitting: a representative population survey in England	48
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?	47
Emotion regulation in substance use disorders: a systematic review and meta‐analysis	45
Bidirectional effects between loneliness, smoking and alcohol use: evidence from a Mendelian randomization study	44
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	44
Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta‐analysis	43

Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies	42
Outcomes associated with the use of medications for opioid use disorder during pregnancy	42
The science of recovery capital: where do we go from here?	42
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA	41
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	41
Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it	40
Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study	40
Tobacco Use and Oral Health	39
Controlled drinking—non‐abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta‐analysis and meta‐regression	39
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use	39
The association between recreational cannabis legalization, commercialization and cannabis‐attributable emergency department visits in Ontario, Canada: an interrupted time–series analysis	38
Alcohol control policy measures and all‐cause mortality in Lithuania: an interrupted time–series analysis	38
For better or for worse? A pre–post exploration of the impact of the COVID‐19 lockdown on cannabis users	36
Changes in drinking days among United States adults during the COVID‐19 pandemic	36
Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non‐drinking?	36
Laws limiting prescribing and dispensing of opioids in the United States, 1989–2019	36
Alcohol use disorder and the liver	36
Cannabis use and co‐use in tobacco smokers and non‐smokers: prevalence and associations with mental health in a cross‐sectional, nationally representative sample of adults in Great Britain, 2020	35
Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses	35
The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta‐analysis	35
Frequency of use, moral incongruence and religiosity and their relationships with self‐perceived addiction to pornography, internet use, social networking and online gaming	34
Factors associated with severity, incidence or persistence of internet gaming disorder in children and adolescents: a 2‐year longitudinal study	34
Carfentanil and the rise and fall of overdose deaths in the United States	34
The real‐world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine	33
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021	33
The relationship between cannabis and schizophrenia: a genetically informed perspective	33
Risk of overdose‐related death for people with a history of incarceration	33
Changes in illicit drug use and markets with the COVID‐19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016–20	32
Iterative categorisation (IC) (part 2): interpreting qualitative data	32
The dawn of a new synthetic opioid era: the need for innovative interventions	32
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy	32
Global prevalence of help‐seeking for problem gambling: A systematic review and meta‐analysis	32
Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP	32
Highly processed foods can be considered addictive substances based on established scientific criteria	31
Clinical management of cannabis withdrawal	31
Alcohol use among young Australian adults in May–June 2020 during the COVID‐19 pandemic: a prospective cohort study	31
Trends in cannabis use among adults with children in the home in the United States, 2004–2017: impact of state‐level legalization for recreational and medical use	31
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial	31
Tobacco use disorder and cardiovascular health	30
Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta‐analysis	30
Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial	30
Youth use of e‐liquid flavours—a systematic review exploring patterns of use of e‐liquid flavours and associations with continued vaping, tobacco smoking uptake or cessation	30
Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network	30
Cognitive boosting interventions for impulsivity in addiction: a systematic review and meta‐analysis of cognitive training, remediation and pharmacological enhancement	29
Associations between financial gambling motives, gambling frequency and level of problem gambling: a meta‐analytic review	29
Evaluating the impact of minimum unit pricing (MUP) on off‐trade alcohol sales in Scotland: an interrupted time–series study	29
Concurrent validity of the Alcohol Purchase Task for measuring the reinforcing efficacy of alcohol: an updated systematic review and meta‐analysis	29
E‐cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial	29
Clarifying gambling subtypes: the revised pathways model of problem gambling	28
Trends in electronic cigarette use and conventional smoking: quantifying a possible ‘diversion’ effect among US adolescents	28

Food addiction in a large community sample of Canadian adults: prevalence and relationship with obesity, body composition, quality of life and impulsivity	28
Cross‐national validation of the social media disorder scale: findings from adolescents from 44 countries	28
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community drug services: real‐world d	27
Is Cannabis being used as a substitute for non‐medical opioids by adults with problem substance use in the United States? A within‐person analysis	27
Dual‐trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study	26
Culturally tailored evidence‐based substance use disorder treatments are efficacious with an American Indian Southwest tribe: an open‐label pilot‐feasibility randomized controlled trial	26
Internet‐based therapy versus face‐to‐face therapy for alcohol use disorder, a randomized controlled non‐inferiority trial	26
Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta‐analysis	25
Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four‐Country survey (2002–14)	25
Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis	25
Clinical management of the alcohol withdrawal syndrome	25
Association of smoking, lung function and COPD in COVID‐19 risk: a two‐step Mendelian randomization study	25
Societal development and the alcohol‐attributable burden of disease	24
Sex differences in factors predicting post‐treatment opioid use	24
Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014–18	24
Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries	24
Alcohol: a probable risk factor of COVID‐19 severity	24
Associations between neighborhood‐level factors and opioid‐related mortality: A multi‐level analysis using death certificate data	24
Predictors of recruitment and retention in randomized controlled trials of behavioural smoking cessation interventions: a systematic review and meta‐regression analysis	24
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials	24
Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta‐analysis of its follow‐up effects	24
Adolescent cannabis and tobacco use are associated with opioid use in young adulthood—12‐year longitudinal study in an urban cohort	23
Jail and overdose: assessing the community impact of incarceration on overdose	23
When the pubs closed: beer consumption before and after the first and second waves of COVID‐19 in Australia	23
A systematic review and meta‐analysis on the association between solitary drinking and alcohol problems in adults	23
Efficacy of brief intervention for harmful and hazardous alcohol use: a systematic review and meta‐analysis of studies from low middle‐income countries	23
Adolescent electronic cigarette use and tobacco smoking in the Millennium Cohort Study	23
All‐cause and cause‐specific mortality among people with regular or problematic cocaine use: a systematic review and meta‐analysis	22
The Stop‐tabac smartphone application for smoking cessation: a randomized controlled trial	22
Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society	22
A randomized clinical trial of a group cognitive–behavioral therapy to reduce alcohol use among human immunodeficiency virus‐infected outpatients in western Kenya	22
Biomarkers of potential harm in people switching from smoking tobacco to exclusive e‐cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e‐cigarettes f	22
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	22
Are psychosocial interventions effective in reducing alcohol consumption during pregnancy and motherhood? A systematic review and meta‐analysis	22
A cluster randomized controlled trial evaluating the effectiveness of the school‐based drug prevention program #Tamojunto2.0	22
Weeding out the truth: a systematic review and meta‐analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence	22
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study	22
Young adult responses to taxes on cigarettes and electronic nicotine delivery systems	22
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017–19	21
Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and	21
Effect of screening, brief intervention and referral to treatment for unhealthy alcohol and other drug use in mental health treatment settings: a randomized controlled trial	21
Estimating the prevalence of problem drug use from drug‐related mortality data	21
Efficacy of non‐invasive brain stimulation interventions in reducing smoking frequency in patients with nicotine dependence: a systematic review and network meta‐analysis of randomized controlled tria	21
Alcohol use disorder and the gut	21
Association between poverty exposure during childhood and adolescence, and drug use disorders and drug‐related crimes later in life	21
Effect of extended‐release naltrexone on alcohol consumption: a systematic review and meta‐analysis	21
Cross‐country differences in age trends in alcohol consumption among older adults: a cross‐sectional study of individuals aged 50 years and older in 22 countries	21
Tracking the decline in Australian adolescent drinking into adulthood	20
Psychosocial interventions for reducing alcohol consumption in sub‐Saharan African settings: a systematic review and meta‐analysis	20
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings	20
Evaluating the effectiveness of the smartphone app, Drink Less, compared with the NHS alcohol advice webpage, for the reduction of alcohol consumption among hazardous and harmful adult drinkers in the	20
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study	20
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database	20
A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder	20
Changes in alcohol‐related hospital visits during COVID‐19 in New York City	20
The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom	19
Injecting drug use, the skin and vasculature	19
The long‐term effectiveness of universal, selective and combined prevention for alcohol use during adolescence: 36‐month outcomes from a cluster randomized controlled trial	19
Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews	19
Alcohol: No Ordinary Commodity—a summary of the third edition	19
Prevalence of alcohol use disorder among individuals who binge eat: a systematic review and meta‐analysis	19
Joint effects of alcohol use, smoking and body mass index as an explanation for the alcohol harm paradox: causal mediation analysis of eight cohort studies	19
Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA	18
Prenatal methamphetamine—impact on the mother and child—a review	18
Setting Limits: Gambling, Science and Public Policy—summary of results	18
Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study	18
The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual‐participant data from 15 international studies	18
Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review	17
All‐cause and suicide mortality among people with methamphetamine use disorder: a nation‐wide cohort study in Taiwan	17
Content analysis of cannabis vaping videos on YouTube	17
A new generation of transdermal alcohol biosensing technology: practical applications, machine ‐learning analytics and questions for future research	17
Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study	17
Changes from 2017 to 2018 in e‐cigarette use and in ever marijuana use with e‐cigarettes among US adolescents: analysis of the National Youth Tobacco Survey	17
Availability of medical cannabis dispensaries and cannabis abuse/dependence‐related hospitalizations in California	17
Impacts of Canada's cannabis legalization on police‐reported crime among youth: early evidence	17
Opioid use disorder and the brain: a clinical perspective	17
A difference‐in‐difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004–17	17
Supporting smoking cessation and preventing relapse following a stay in a smoke‐free setting: a meta‐analysis and investigation of effective behaviour change techniques	17
The associations of smoking dependence motives with depression among daily smokers	17
Coordination, framing and innovation: the political sophistication of public health advocates in Ireland	17

Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial	16
Need for comprehensive and timely data to address the opioid overdose epidemic without a blindfold	16
Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17	16
Assessing New Zealand’s Cannabis Legalization and Control Bill: prospects and challenges	16
Causal inference with observational data in addiction research	16
Loot boxes are more prevalent in United Kingdom video games than previously considered: updating Zendle et al. (2020)	16
Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta‐analysis	16
Tobacco use during pregnancy	16
Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters	16
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	16
Meta‐analysis of associations between empathy and alcohol use and problems in clinical and non‐clinical samples	16
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an em	16
Prevalence of co‐occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada	16
The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community	16
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	16
Community‐based smoking cessation treatment for adults with high anxiety sensitivity: a randomized clinical trial	15
Reward‐related decision‐making deficits in internet gaming disorder: a systematic review and meta‐analysis	15
Rapid changes in illegally manufactured fentanyl products and prices in the United States	15
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study	15
Health warning labels and alcohol selection: a randomised controlled experiment in a naturalistic shopping laboratory	15
Is substance use changing because of the COVID‐19 pandemic? Conceptual and methodological considerations to delineating the impact of the COVID‐19 pandemic on substance use and disorder	15
Illicit drug use and oral health	15
A wastewater‐based assessment of the impact of a minimum unit price (MUP) on population alcohol consumption in the Northern Territory, Australia	15
Alcohol policy and gender: a modelling study estimating gender‐specific effects of alcohol pricing policies	15
Prices, taxes and alcohol use: a systematic umbrella review	15
The impact of changes in COVID‐19 lockdown restrictions on alcohol consumption and drinking occasion characteristics in Scotland and England in 2020: an interrupted time‐series analysis	15
Does heroin‐assisted treatment reduce crime? A review of randomized‐controlled trials	15
Drug‐related harm coinciding with income assistance payments: results from a community‐based cohort of people who use drugs	15
Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod‐based e‐cigarettes	15
The association of telomere length with substance use disorders: a systematic review and meta‐analysis of observational studies	15
Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double‐blind, multi‐site randomized controlled trial	15
Genome‐wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci	15
Addicted to smoking or addicted to nicotine? A focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non‐smokers and dual users of cigarettes and e	14
Prevalence and correlates of receptive syringe‐sharing among people who inject drugs in rural Appalachia	14
Clinical Management of Opioid Withdrawal	14
The impact of removing former drinkers from genome‐wide association studies of AUDIT‐C	14
Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses	14
#TurntTrending: a systematic review of substance use portrayals on social media platforms	14
Telephone‐based motivational interviewing enhanced with individualised personality‐specific coping skills training for young people with alcohol‐related injuries and illnesses accessing emergency or r	14
Kratom use in the United States: a diverse and complex profile	14
A systematic review of qualitative research on substance use among refugees	14
Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes	14
Encouraging and evaluating limit‐setting among on‐line gamblers: a naturalistic randomized controlled trial	14
The impact of comprehensive tobacco control policies on cardiovascular diseases in Beijing, China	14
Brief overview of the WHO Collaborative Project on the Development of New International Screening and Diagnostic Instruments for Gaming Disorder and Gambling Disorder	14
Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV‐negative men who have sex with men	14
England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking‐attributable deaths in England	14
Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients	14
Comparison of a web‐push survey research protocol with a mailed paper and pencil protocol in the Monitoring the Future panel survey	13
Association of quarterly prevalence of e‐cigarette use with ever regular smoking among young adults in England: a time–series analysis between 2007 and 2018	13
Physicians’ very brief (30‐sec) intervention for smoking cessation on 13 671 smokers in China: a pragmatic randomized controlled trial	13
Association of e‐cigarette advertising with e‐cigarette and cigarette use among US adults	13
Home delivery of legal intoxicants in the age of COVID‐19	13
Trends in cannabis use and attitudes toward legalization and use among Australians from 2001–2016: an age‐period‐cohort analysis	13
A first pass, using pre‐history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems, 1970s–c. 2018	13
Opioid overdose experiences in a sample of US adolescents and young adults: a thematic analysis	13
Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial	13
Age‐based preferences for risk communication in the fentanyl era: ‘A lot of people keep seeing other people die and that's not enough for them’	13
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?	13
User pathways of e‐cigarette use to support long term tobacco smoking relapse prevention: a qualitative analysis	13
Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use	13
Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned	13
Aberrations in peripheral inflammatory cytokine levels in substance use disorders: a meta‐analysis of 74 studies	13
The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic	13
Trends in MDMA‐related mortality across four countries	13
Skin‐cleaning among hospitalized people who inject drugs: a randomized controlled trial	13
Association between punitive policies and neonatal abstinence syndrome among Medicaid‐insured infants in complex policy environments	13
Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids	13
Genetic architecture of four smoking behaviors using partitioned SNP heritability	13
Comparison of e‐cigarette use prevalence and frequency by smoking status among youth in the United States, 2014–19	13
Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis	13
Alcohol consumption trajectories over the Australian life course	13
Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid‐use disorder: an ecological momentary assessment study	13
Regulation and accreditation of addictive behaviour applications—navigating the landscape	13
Developmental patterns of tobacco product and cannabis use initiation in high school	12
A new perspective on European drinking cultures: a model‐based approach to determine variations in drinking practices among 19 European countries	12
Alcohol use and cognitive functioning in young adults: improving causal inference	12
Impact of reducing alcohol consumption through price‐based policies on cancer incidence in Germany 2020–50—a simulation study	12
Effectiveness of offering tailored text message, self‐help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta‐analysis	12
Quantification of prenatal marijuana use: evaluation of the correlation between self‐report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals	12
Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID‐19	12
Reward drinking and naltrexone treatment response among young adult heavy drinkers	12
Illegal drug market responses to state recreational cannabis laws	12
Modeling the impact of COVID‐19 pandemic‐driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States	12
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia	12
Association of vaping‐related lung injuries with rates of e‐cigarette and cannabis use across US states	12
Hazardous and harmful alcohol use in the Northern Territory, Australia: the impact of alcohol policy on critical care admissions using an extended sampling period	12
Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID‐19 pandemic in New South Wales, Australia	12
Avoidance of tobacco health warnings? An eye‐tracking approach	12
Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map	12
Alcohol use disorder and non‐fatal suicide attempt: findings from a Swedish National Cohort Study	12
Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States	12
Sex‐Specific Risk Profiles for Suicide Among Persons with Substance Use Disorders in Denmark	12
Affected other interventions: a systematic review and meta‐analysis across addictions	12
Effects of a minimal‐guided on‐line intervention for alcohol misuse in Estonia: a randomized controlled trial	11